Program
Day 1 (May 7, Thu)
13:10-13:50
Plenary Lecture Ⅰ
Dae Hyun Lim (Korea)
13:10-13:50
The Global Burden of Allergic Diseases: WAO Strategies for a Healthier Future
Mário Morais-Almeida (Portugal)
13:50-14:10
Coffee Break
14:10-15:40
KAAACI-WAO Symposium. Global Strategies for Asthma & Allergy: Evolving Concepts from Origins to Future Technologies
Sukil Chang (Korea), Mário Morais-Almeida (Portugal)
14:10-14:40
The Life Course of Asthma: From Viral Origins to Remission and Persistence
Nikolaos G. Papadopoulos (Greece)
14:40-15:10
A Decade of Treatable Traits: What Truly Matters in Severe Asthma?
Woo-Jung Song (Korea)
15:10-15:40
The Future of Allergy Care: Digital Health and Real-World Evidence for Precision Medicine
Mário Morais-Almeida (Portugal)
15:40-16:00
Break
16:00-17:30
Symposium Ⅱ. Multidimensional Drivers of Atopic Dermatitis: Biology, Microbiome Ecology, Environment
Kangmo Ahn (Korea), Dong Hun Lee (Korea)
16:00-16:30
From Barrier Stress to Pruritus: Translational Immunology of Atopic Dermatitis
Tetsuya Honda (Japan)
16:30-17:00
Neuroimmune–Lipid Crosstalk in Chronic Itch
Hye One Kim (Korea)
17:00-17:30
Environmental and Lifestyle Determinants of Atopic Dermatitis: Lessons from Birth Cohort Studies
Kiwako Yamamoto-Hanada (Japan)
17:30-17:50
Break
17:50-18:30
Sponsored Symposium Ⅰ (GSK Korea)
Dong Ho Nahm (Korea)
17:50-18:30
The Clinical Impact of IL-5 Inhibition in Severe Eosinophilic Asthma: Can Mepolizumab Modify Disease Course?
John Oppenheimer (USA)
14:10-15:40
Symposium Ⅰ. Advances in Hypereosinophilic Disorders
Young-Il Koh (Korea), Tae-Bum Kim (Korea)
14:10-14:40
Hypereosinophilic Syndromes: an Overview
Amy Klion (USA)
14:40-15:10
EGPA: Early Recognition, Biomarkers, and Biologic Therapeutics
Noeul Kang (Korea)
15:10-15:40
Biomarkers in Eosinophilic Diseases: From Bench to Clinical Application
Chang Keun Kim (Korea)
15:40-16:00
Break
16:00-17:30
Working Group Symposium Ⅰ. Neurobiology of Chronic Cough: Translating Science into Clinical Impact
Stuart Mazzone (Australia), You Sook Cho (Korea)
16:00-16:30
Placebo Effects on Cough
Stuart Mazzone (Australia)
16:30-17:00
Data-driven Insights into Cough Measurement
Hyeon-Kyoung Koo (Korea)
17:00-17:30
From Symptom to Disease: Redefining Chronic Cough Beyond RCTs
Eun-Jung Jo (Korea)
17:30-17:50
Break
17:50-18:30
Sponsored Symposium Ⅱ (Takeda)
Hye Ryun Kang (Korea)
17:50-18:30
Beyond Attacks: Disease Control in HAE with Lanadelumab
Daisuke Honda (Japan)
14:10-15:40
KAAACI-KATRD Airway Symposium Ⅰ. A Comprehensive Ecosystem for Airway Diseases: Lifespan, Guidelines, and Rehabilitation
Kwang Ha Yoo (Korea), Dae Hyun Lim (Korea)
14:10-14:40
Understanding and Managing Airway Diseases Across the Lifespan
Kyung Won Kim (Korea)
14:40-15:10
The Airway Disease Guideline Ecosystem: From Evidence Generation to Clinical Implementation
Hyun-Jung Kim (Korea)
15:10-15:40
Sarcopenia, Frailty, and Pulmonary Rehabilitation in Chronic Airway Diseases
Tai Joon An (Korea)
15:40-16:00
Break
16:00-17:30
KAAACI-KATRD Airway Symposium Ⅱ. The Spectrum of Advanced Airway Diseases: Systemic Overlaps and Structural Changes
An-Soo Jang (Korea), Hyoung Kyu Yoon (Korea)
16:00-16:30
Systemic Eosinophilia: Uniting the Pulmonologist’s Lung and the Allergist’s Systemic View
Ga-Young Ban (Korea)
16:30-17:00
From Sensitization to Destruction: Navigating the Spectrum from ABPA to CPA
Ha-Kyeong Won (Korea)
17:00-17:30
When Asthma Leaves a Mark: Understanding Asthma with Persistent Airflow Limitation
Jung-Kyu Lee (Korea)
17:30-17:50
Break
17:50-18:30
Sponsored Symposium Ⅲ (AstraZeneca Korea)
Byung-Jae Lee (Korea)
17:50-18:30
Tezepelumab in Severe Asthma: From Downstream to Upstream Targeting
Woo-Jung Song (Korea)